(R)-3-(2-Fluoro-6-nitrophenoxy)pyrrolidine hydrochloride, 95.0%, 1g

2,6-Dibenzhydryl-2,6-diazaspiro[3.3]heptane, 98%, 2g

(R)-1-(TERT-BUTOXYCARBONYL)-4,4-DIFLUOROPIPERIDINE-2-CARBOXYLIC ACID, 95%, 100mg

METHYL 4-BROMO-3,5-DIMETHOXYBENZOATE, 95.0%, 5g

(S)-3-Phenylcyclohexanone, 95.0%, 1g

4-(4-Methylpiperazino)benzonitrile, 95.0%, 10g

2-(1-Chlorocyclopropyl)-1-(2-chlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol, 95.0%, 25g

(1H-Benzo[d]imidazol-2-yl)methanamine dihydrochloride, 95.0%, 10g

GC-Kapillarsäule ROTI®Cap-5 MS Ultra, L 50 m, Ø-Innen 0,20 mm, Filmd. 0,35 µm, 1 Stück

n,n-Diethylpyrrolidin-3-amine, 98%, 5g

2-(2-Fluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 1g

4,5-Bis(diphenylphosphino)-9,9-dimethylxanthene>98.0%(GC)25g

(S)-3-Amino-4-oxo-4-(((R)-1-oxo-1-((2,2,4,4-tetramethylthietan-3-yl)amino)propan-2-yl)amino)butanoic acid, 95.0%, 1g